ArticleThe Journal of international medical research2026
Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation.
Kok Hoe Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.